1. Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non-emetic Doses
    Zhong-Zhen Zhou et al, 2017, ACS Chem. Neurosci. CrossRef
  2. The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain
    Chi-Hua Guo et al, 2016 CrossRef
  3. Water-Soluble Polymer Assists N-Methyl-D-Aspartic Acid Receptor 2B siRNA Delivery to Relieve Chronic Inflammatory Pain In Vitro and In Vivo
    Jie Peng et al, 2018, Pain Research and Management CrossRef
  4. The antidepressant effects of rosiglitazone on rats with depression induced by neuropathic pain
    Jian Zong et al, 2018, Life Sciences CrossRef
  5. Following spinal cord injury, PDE4B drives an acute, local inflammatory response and a chronic, systemic response exacerbated by gut dysbiosis and endotoxemia
    Scott A. Myers et al, 2018, Neurobiology of Disease CrossRef
  6. RNA control in pain: Blame it on the messenger
    June Bryan I. de la Peña et al, 2019, WIREs RNA CrossRef
  7. Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages
    Jing-Xing Yang et al, 2017, Sci Rep CrossRef
  8. PDE4B as a microglia target to reduce neuroinflammation.
    Damien D Pearse et al, 2016, Glia CrossRef
  9. Low concentration of Bupivacaine ameliorates painful diabetic neuropathy by mediating miR-23a/PDE4B axis in microglia
    Xianjie Zhang et al, 2020, European Journal of Pharmacology CrossRef
  10. Antiallodynic action of phosphodiesterase inhibitors in a mouse model of peripheral nerve injury
    Salim Megat et al, 2022, Neuropharmacology CrossRef
  11. Inhibition of phosphodiesterase‐4 in the spinal dorsal horn ameliorates neuropathic pain via cAMP‐cytokine‐Cx43 signaling in mice
    Fang‐fang Zhang et al, 2022, CNS Neurosci Ther CrossRef